| 摘要 |
medicine. SUBSTANCE: described are new androstane steroids of formula I: wherein P1 is oxo, alpha-(beta- hydroxy, alpha-(beta-)-C1-4 alkoxy or alpha-(beta- benzyloxy; P2 is C1-4 alkyl, hydroxy C1-4 alkyl; P3 is nonexistent or C1-4 alkyl ; P4 is hydrogen, oxo or hydroxy; P5 is one two hydrogen atoms, methyl of methylene; P6 is hydrogen, which are ligand semichemical products binding with neutroepithelial receptors. EFFECT: improved properties of the title compounds. 9 cl, 28 ex, 37 dwg, 1 tbl
|
